336 related articles for article (PubMed ID: 18593000)
1. [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].
Kaneko M; Tomioka H; Kaneda T; Kubot M; Tani S; Fujii H; Katsuyama E; Okazaki M
Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):505-9. PubMed ID: 18593000
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis.
Yamada Y; Uchida Y; Tatsumi K; Yamaguchi T; Kimura H; Kitahara H; Kuriyama T
J Nucl Med; 1998 Jul; 39(7):1160-6. PubMed ID: 9669387
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET as a predictor of pulmonary function in sarcoidosis.
Keijsers RG; Verzijlbergen EJ; van den Bosch JM; Zanen P; van de Garde EM; Oyen WJ; Grutters JC
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):123-9. PubMed ID: 22117503
[TBL] [Abstract][Full Text] [Related]
5. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
Takanami K; Kaneta T; Yamada T; Kinomura S; Yamada S; Fukuda H; Takahashi S
Clin Nucl Med; 2008 Apr; 33(4):258-61. PubMed ID: 18356663
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of fluorodeoxyglucose-positron emission tomography in a case of pleural sarcoidosis].
Hattori T; Konno S; Inomata T; Nasuhara Y; Betsuyaku T; Nishimura M
Nihon Kokyuki Gakkai Zasshi; 2009 Jul; 47(7):658-62. PubMed ID: 19637812
[TBL] [Abstract][Full Text] [Related]
7. Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET.
Keijsers RG; Grutters JC; Thomeer M; Du Bois RM; Van Buul MM; Lavalaye J; Van Den Bosch JM; Verzijlbergen FJ
Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):66-71. PubMed ID: 21242947
[TBL] [Abstract][Full Text] [Related]
8. [A case of pulmonary hyalinizing granuloma with high-grade uptake on FDG-PET mimicking metastatic lung cancer].
Kaneta T; Saito A; Akiyama T; Takahashi Y; Takahashi R; Kudou K
Nihon Kokyuki Gakkai Zasshi; 2009 Oct; 47(10):953-9. PubMed ID: 19882922
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic involvement detected with (18)F-FDG PET/CT in disseminated sarcoidosis.
Delgado-Bolton RC; Arias Navalón JA; Rodríguez Alfonso B; Delgado-Bolton AN; Pérez-Castejón MJ; Sánchez-Escribano R; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
Rev Esp Med Nucl; 2011; 30(1):29-32. PubMed ID: 20638156
[TBL] [Abstract][Full Text] [Related]
10. Fluorodeoxyglucose PET scan in pulmonary sarcoidosis during treatment with inhaled and oral corticosteroids.
Milman N; Mortensen J; Sloth C
Respiration; 2003; 70(4):408-13. PubMed ID: 14512678
[TBL] [Abstract][Full Text] [Related]
11. Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis.
Bolat S; Berding G; Dengler R; Stangel M; Trebst C
J Neurol Sci; 2009 Dec; 287(1-2):257-9. PubMed ID: 19755199
[TBL] [Abstract][Full Text] [Related]
12. F-18 fluorodeoxyglucose and F-18 fluorothymidine positron emission tomography/computed tomography imaging in a case of neurosarcoidosis.
Kim SK; Im HJ; Kim W; Kim TS; Hwangbo B; Kim HJ
Clin Nucl Med; 2010 Feb; 35(2):67-70. PubMed ID: 20090446
[TBL] [Abstract][Full Text] [Related]
13. Sarcoidosis misdiagnosed as malignant tumors: a case report.
Li Z; Li X; Song Z; Liu J; Dong M; Shi T; Ren D; Xu S; Chen J
World J Surg Oncol; 2015 Dec; 13():333. PubMed ID: 26652015
[TBL] [Abstract][Full Text] [Related]
14.
Chauvelot P; Skanjeti A; Jamilloux Y; de Parisot A; Broussolle C; Denis P; Ramackers JM; Giammarile F; Kodjikian L; Seve P
Br J Ophthalmol; 2019 Nov; 103(11):1650-1655. PubMed ID: 30658987
[TBL] [Abstract][Full Text] [Related]
15. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
[TBL] [Abstract][Full Text] [Related]
16. Use of integrated FDG-PET/CT in sarcoidosis.
Krüger S; Buck AK; Mottaghy FM; Pauls S; Schelzig H; Hombach V; Reske SN
Clin Imaging; 2008; 32(4):269-73. PubMed ID: 18603181
[TBL] [Abstract][Full Text] [Related]
17. Impact of [18F]-fluorodeoxyglucose ([18F]-FDG) imaging in sarcoidosis: unsuspected neurosarcoidosis discovered by [18F]-FDG PET and early metabolic response to corticosteroid therapy.
Aide N; Benayoun M; Kerrou K; Khalil A; Cadranel J; Talbot JN
Br J Radiol; 2007 Mar; 80(951):e67-71. PubMed ID: 17548505
[TBL] [Abstract][Full Text] [Related]
18. Biopsy findings in PET/CT-positive lung lesions in a community hospital.
Lobrano MB; Hayman E; Dekelbaum M; Campeau R
J La State Med Soc; 2005; 157(6):319-24. PubMed ID: 16579344
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis.
Ozawa Y; Yamamoto H; Yasuo M; Komatsu M; Ushiki A; Hamano H; Uehara T; Kawakami S; Fujita A; Fujinaga Y; Oguchi K; Kawa S; Hanaoka M
Nagoya J Med Sci; 2020 Feb; 82(1):101-111. PubMed ID: 32273638
[TBL] [Abstract][Full Text] [Related]
20. The scar sign: a useful finding on FDG PET/CT to distinguish sarcoidosis from other causes of lymphadenopathy.
Lu SJ; Lee VK; Loo SW
Clin Nucl Med; 2013 Mar; 38(3):205-8. PubMed ID: 23354040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
